343 related articles for article (PubMed ID: 33539074)
21. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model.
Ben David-Naim M; Grad E; Aizik G; Nordling-David MM; Moshel O; Granot Z; Golomb G
Biomaterials; 2017 Nov; 145():154-167. PubMed ID: 28863309
[TBL] [Abstract][Full Text] [Related]
22. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo.
Zhupanyn P; Ewe A; Büch T; Malek A; Rademacher P; Müller C; Reinert A; Jaimes Y; Aigner A
J Control Release; 2020 Mar; 319():63-76. PubMed ID: 31866504
[TBL] [Abstract][Full Text] [Related]
23. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
[TBL] [Abstract][Full Text] [Related]
24. Overcoming Multidrug Resistance by Codelivery of MDR1-Targeting siRNA and Doxorubicin Using EphA10-Mediated pH-Sensitive Lipoplexes: In Vitro and In Vivo Evaluation.
Zhang J; Du Z; Pan S; Shi M; Li J; Yang C; Hu H; Qiao M; Chen D; Zhao X
ACS Appl Mater Interfaces; 2018 Jun; 10(25):21590-21600. PubMed ID: 29798663
[TBL] [Abstract][Full Text] [Related]
25. Efficacious cellular codelivery of doxorubicin and EGFP siRNA mediated by the composition of PLGA and PEI protected gold nanoparticles.
Kumar K; Vulugundam G; Jaiswal PK; Shyamlal BRK; Chaudhary S
Bioorg Med Chem Lett; 2017 Sep; 27(18):4288-4293. PubMed ID: 28838699
[TBL] [Abstract][Full Text] [Related]
26. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
[TBL] [Abstract][Full Text] [Related]
27. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
[TBL] [Abstract][Full Text] [Related]
28. Novel non-mulberry silk fibroin nanoparticles with enhanced activity as potential candidate in nanocarrier mediated delivery system.
Baruah RR; Chandra Kalita M; Devi D
RSC Adv; 2020 Feb; 10(15):9070-9078. PubMed ID: 35496565
[TBL] [Abstract][Full Text] [Related]
29. Dual Targeted Nanoparticles for the Codelivery of Doxorubicin and siRNA Cocktails to Overcome Ovarian Cancer Stem Cells.
Chen L; Luo J; Zhang J; Wang S; Sun Y; Liu Q; Cheng C
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511335
[TBL] [Abstract][Full Text] [Related]
30. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
[TBL] [Abstract][Full Text] [Related]
31. Nano-adjuvant based on silk fibroin for the delivery of recombinant hepatitis B surface antigen.
Rezaei F; Keshvari H; Shokrgozar MA; Doroud D; Gholami E; Khabiri A; Farokhi M
Biomater Sci; 2021 Apr; 9(7):2679-2695. PubMed ID: 33605970
[TBL] [Abstract][Full Text] [Related]
32. Targeted and Efficient Delivery of siRNA Using Tunable Polymeric Hybrid Micelles for Tumor Therapy.
Hao F; Dong S; Yang C; Li Z; Cheng Z; Zhong L; Teng L; Meng Q; Lu J; Wu F; Xie J; Teng L; Lee RJ
Anticancer Res; 2019 Mar; 39(3):1169-1178. PubMed ID: 30842146
[TBL] [Abstract][Full Text] [Related]
33. Cross-linked nanoparticles of silk fibroin with proanthocyanidins as a promising vehicle of indocyanine green for photo-thermal therapy of glioma.
ZhuGe DL; Wang LF; Chen R; Li XZ; Huang ZW; Yao Q; Chen B; Zhao YZ; Xu HL; Yuan JD
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4293-4304. PubMed ID: 31810396
[TBL] [Abstract][Full Text] [Related]
34. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
[TBL] [Abstract][Full Text] [Related]
35. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
[TBL] [Abstract][Full Text] [Related]
36. Multifunctional Superparamagnetic Nanoparticles: From Synthesis to siRNA Delivery.
Arami S; Mahdavi M; Rashidi MR; Fathi M; Hejazi MS; Samadi N
Curr Pharm Des; 2017; 23(16):2400-2409. PubMed ID: 27799034
[TBL] [Abstract][Full Text] [Related]
37. Sequence-dependent combination therapy with doxorubicin and a survivin-specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinoma.
Ghosh SK; Yigit MV; Uchida M; Ross AW; Barteneva N; Moore A; Medarova Z
Int J Cancer; 2014 Apr; 134(7):1758-66. PubMed ID: 24114765
[TBL] [Abstract][Full Text] [Related]
38. Novel polyacrylate-based cationic nanoparticles for survivin siRNA delivery combined with mitoxantrone for treatment of breast cancer.
Arami S; Mahdavi M; Rashidi MR; Fathi M; Hejazi MS; Samadi N
Biologicals; 2016 Nov; 44(6):487-496. PubMed ID: 27712979
[TBL] [Abstract][Full Text] [Related]
39. Biodistribution and Toxicity Assessment of Superparamagnetic Iron Oxide Nanoparticles In Vitro and In Vivo.
Yu Q; Xiong XQ; Zhao L; Xu TT; Bi H; Fu R; Wang QH
Curr Med Sci; 2018 Dec; 38(6):1096-1102. PubMed ID: 30536075
[TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of silk fibroin/oligochitosan nanoparticles for siRNA delivery.
Shahbazi B; Taghipour M; Rahmani H; Sadrjavadi K; Fattahi A
Colloids Surf B Biointerfaces; 2015 Dec; 136():867-77. PubMed ID: 26547314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
